The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-2-acetamido-6-amino-N-((S)-6-amino-1-(((S)-2-(benzylamino)-2-oxo-1-(4-((4-(trifluoromethyl)benzyl)oxy)phenyl)ethyl)amino)-1-oxohexan-2-yl)hexanamide ID: ALA5177478
Chembl Id: CHEMBL5177478
PubChem CID: 168272603
Max Phase: Preclinical
Molecular Formula: C37H47F3N6O5
Molecular Weight: 712.81
Associated Items:
Names and Identifiers Canonical SMILES: CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCc1ccccc1)c1ccc(OCc2ccc(C(F)(F)F)cc2)cc1
Standard InChI: InChI=1S/C37H47F3N6O5/c1-25(47)44-31(11-5-7-21-41)34(48)45-32(12-6-8-22-42)35(49)46-33(36(50)43-23-26-9-3-2-4-10-26)28-15-19-30(20-16-28)51-24-27-13-17-29(18-14-27)37(38,39)40/h2-4,9-10,13-20,31-33H,5-8,11-12,21-24,41-42H2,1H3,(H,43,50)(H,44,47)(H,45,48)(H,46,49)/t31-,32-,33-/m0/s1
Standard InChI Key: HHIMYGNCUXLNRB-ZDCRTTOTSA-N
Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 712.81Molecular Weight (Monoisotopic): 712.3560AlogP: 4.01#Rotatable Bonds: 20Polar Surface Area: 177.67Molecular Species: BASEHBA: 7HBD: 6#RO5 Violations: 2HBA (Lipinski): 11HBD (Lipinski): 8#RO5 Violations (Lipinski): 3CX Acidic pKa: 11.82CX Basic pKa: 10.49CX LogP: 2.67CX LogD: -2.35Aromatic Rings: 3Heavy Atoms: 51QED Weighted: 0.10Np Likeness Score: -0.55
References 1. Colarusso S, Ferrigno F, Ponzi S, Pavone F, Conte I, Abate L, Beghetto E, Missineo A, Amaudrut J, Bresciani A, Paonessa G, Tomei L, Montalbetti C, Bianchi E, Toniatti C, Ontoria JM.. (2022) SAR evolution towards potent C-terminal carboxamide peptide inhibitors of Zika virus NS2B-NS3 protease., 57 [PMID:35123179 ] [10.1016/j.bmc.2022.116631 ]